Protara Therapeutics, Inc. (TARA) stock
TARANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.32−0.06 (-2.52%)
Close on Nov 17, 2026Market cap $137.10MP/E –Yield –
Protara Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Protara Therapeutics's enterprise value was $12.31M on Nov 11, 2026, against $151.36M a year earlier. Over the last 5 years it ranged from -$69.53M to $185.26M, with a median of -$32.46M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $12.31M | -83.0% |
| 2025 | Dec 31, 2025 | $72.26M | +170.8% |
| 2024 | Dec 31, 2024 | $26.68M | – |
| 2023 | Dec 29, 2023 | -$53.47M | – |
| 2022 | Dec 30, 2022 | -$66.87M | – |
| 2021 | Dec 31, 2021 | -$17.92M | -120.1% |
| 2020 | Dec 31, 2020 | $89.20M | – |
| 2019 | Dec 31, 2019 | -$1.27M | -107.3% |
| 2018 | Dec 31, 2018 | $17.43M | – |
| 2017 | Dec 29, 2017 | -$13.92M | – |
| 2016 | Dec 30, 2016 | -$15.49M | -108.4% |
| 2015 | Dec 31, 2015 | $185.10M | – |
| 2014 | Dec 31, 2014 | -$19.20M | – |
See a number that looks wrong?